Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-18

Clinical Trial Update: Dose-Escalation, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GB-6002 Local Infiltration in Healthy Male Adults [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of GB-6002 delivered by local infiltration in healthy male…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GB-6002

Snippet

Sponsor: G2GBio, Inc. | Conditions: Pain, Postoperative | Phase 1 | Status: COMPLETED